A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key advance in understanding neurodegenerative disorders such as Alzheimer's and ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key advance in understanding ...

A new study suggests that targeting the protein alpha-synuclein could be a possible new target for treating melanoma.

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the development of melanoma by promoting excessive DNA repair and cell ...

Neurodegenerative diseases like Huntington’s disease pose significant challenges to modern medicine. Recent research has ...

Researchers have uncovered the critical role of the "fuzzy coat" of α-synuclein in forming Lewy bodies associated with ...

Oppenheimer & Co. Inc. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.

Why do problems occur with a special variant of 'protein glues', the split inteins, that severely limit their use in producing proteins? A team has now answered this question.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The company granted stock options to purchase an aggregate of 79,950 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 54,750 shares of Nurix common ...